AT395349T - Polycyclic guanine phosphodiesterase inhibitors - Google Patents

Polycyclic guanine phosphodiesterase inhibitors

Info

Publication number
AT395349T
AT395349T AT02761506T AT02761506T AT395349T AT 395349 T AT395349 T AT 395349T AT 02761506 T AT02761506 T AT 02761506T AT 02761506 T AT02761506 T AT 02761506T AT 395349 T AT395349 T AT 395349T
Authority
AT
Austria
Prior art keywords
phosphodiesterase inhibitors
polycyclic guanine
guanine
polycyclic
phosphodiesterase
Prior art date
Application number
AT02761506T
Other languages
German (de)
Inventor
Theodros Asberom
Yueqing Hu
Dmitri Pissarnitski
Ruo Xu
Yuguang Wang
Samuel Chackalamannil
John Clader
Andrew Stamford
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to US31539501P priority Critical
Application filed by Schering Corp filed Critical Schering Corp
Publication of AT395349T publication Critical patent/AT395349T/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by C07D451/00 - C07D477/00
    • C07D487/12Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
    • C07D487/14Ortho-condensed systems
AT02761506T 2001-08-28 2002-08-26 Polycyclic guanine phosphodiesterase inhibitors AT395349T (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US31539501P true 2001-08-28 2001-08-28

Publications (1)

Publication Number Publication Date
AT395349T true AT395349T (en) 2008-05-15

Family

ID=23224209

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02761506T AT395349T (en) 2001-08-28 2002-08-26 Polycyclic guanine phosphodiesterase inhibitors

Country Status (13)

Country Link
US (1) US6969719B2 (en)
EP (1) EP1421084B1 (en)
JP (2) JP4450365B2 (en)
CN (2) CN1315835C (en)
AR (1) AR036674A1 (en)
AT (1) AT395349T (en)
CA (1) CA2457944C (en)
DE (1) DE60226615D1 (en)
ES (1) ES2302835T3 (en)
HK (1) HK1064668A1 (en)
MX (1) MXPA04001891A (en)
PE (1) PE04152003A1 (en)
WO (1) WO2003020724A1 (en)

Families Citing this family (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020091129A1 (en) * 2000-11-20 2002-07-11 Mitradev Boolell Treatment of premature ejaculation
JP3945985B2 (en) * 2000-12-28 2007-07-18 株式会社リコー Digital camera device
AU2002331064B2 (en) 2001-08-10 2007-08-23 Palatin Technologies, Inc. Peptidomimetics of biologically active metallopeptides
AT395349T (en) * 2001-08-28 2008-05-15 Schering Corp Polycyclic guanine phosphodiesterase inhibitors
WO2003020702A2 (en) 2001-08-31 2003-03-13 The Rockefeller University Phosphodiesterase activity and regulation of phosphodiesterase 1-b-mediated signaling in brain
EP1442042A1 (en) * 2001-11-09 2004-08-04 Schering Corporation Polycyclic guanine derivative phosphodiesterase v inhibitors
JP2005529934A (en) * 2002-05-31 2005-10-06 シェーリング コーポレイションSchering Corporation Xanthine phosphodiesterase v inhibitors and processes for preparing the precursor
EP1719772A1 (en) * 2002-05-31 2006-11-08 Schering Corporation Process for preparing xanthine phosphodiesterase v inhibitors and precursors thereof
DE10230311A1 (en) * 2002-07-05 2004-01-22 Degussa Ag Process for the catalyst-free production of O-alkyl-N-cyanformimidaten
JP2007512345A (en) * 2003-11-21 2007-05-17 シェーリング コーポレイションSchering Corporation Phosphodiesterase v inhibitor formulation
AU2005249794A1 (en) 2004-06-04 2005-12-15 Teva Pharmaceutical Industries, Ltd. Pharmaceutical composition containing irbesartan
JP2008534505A (en) * 2005-03-25 2008-08-28 メルク エンド カムパニー インコーポレーテッドMerck & Company Incoporated Method for the treatment of men by reductase inhibitors - testosterone supplements and 5 alpha
KR20140022114A (en) 2005-06-06 2014-02-21 다케다 야쿠힌 고교 가부시키가이샤 Organic compounds
EP1896076A2 (en) * 2005-06-27 2008-03-12 Daniel Drai Compositions and methods for enhancement of sexual function
US20070042957A1 (en) * 2005-08-19 2007-02-22 Mayo Foundation For Medical Education And Research Type v phosphodiesterase inhibitors and natriuretic polypeptides
WO2007025103A2 (en) * 2005-08-23 2007-03-01 Intra-Cellular Therapies, Inc. Organic compounds for treating reduced dopamine receptor signalling activity
WO2007070426A2 (en) * 2005-12-09 2007-06-21 Mayo Foundation For Medical Education And Research Sexual dysfunction
JP2007290996A (en) * 2006-04-24 2007-11-08 Ube Ind Ltd Method for producing 4-aminotetrahydropyran
JP2010509399A (en) 2006-11-13 2010-03-25 イントラ−セルラー・セラピーズ・インコーポレイテッドIntra−Cellular Therapies, Inc. Organic compound
WO2008070095A1 (en) 2006-12-05 2008-06-12 Intra-Cellular Therapies, Inc. Novel uses
BRPI0812909A2 (en) * 2007-06-21 2014-12-09 Schering Corp guanine derivatives polycyclic and methods of use thereof.
US8846693B2 (en) 2007-12-06 2014-09-30 Intra-Cellular Therapies, Inc. Optionally substituted pyrazolo[3,4-d]pyrimidine-4,6-diones
CN104402893A (en) 2007-12-06 2015-03-11 武田药品工业株式会社 Organic compounds
US8536159B2 (en) 2008-12-06 2013-09-17 Intra-Cellular Therapies, Inc. Organic compounds
CA2740388A1 (en) * 2008-12-06 2010-06-10 Intra-Cellular Therapies, Inc. Organic compounds
EA201170771A1 (en) 2008-12-06 2012-01-30 Интра-Селлулар Терапиз, Инк. organic compounds
CA2740385A1 (en) 2008-12-06 2010-06-10 Intra-Cellular Therapies, Inc. Organic compounds
ES2551325T3 (en) 2008-12-06 2015-11-18 Intra-Cellular Therapies, Inc. organic compounds
JP5813511B2 (en) 2008-12-06 2015-11-17 イントラ−セルラー・セラピーズ・インコーポレイテッドIntra−Cellular Therapies, Inc. Organic compound
CN101747282A (en) 2008-12-10 2010-06-23 上海特化医药科技有限公司;中国科学院上海药物研究所 Phenyl pyrimidone compounds, pharmaceutical compositions and preparation methods and uses thereof
US20110312978A1 (en) * 2009-02-25 2011-12-22 Robert Davis Pde1 inhibitors for ophthalmic disorders
JP2012526810A (en) 2009-05-13 2012-11-01 イントラ−セルラー・セラピーズ・インコーポレイテッドIntra−Cellular Therapies, Inc. Organic compound
SG178279A1 (en) 2009-08-05 2012-03-29 Intra Cellular Therapies Inc Novel regulatory proteins and inhibitors
EP2523561A4 (en) * 2009-12-22 2013-06-05 Merck Sharp & Dohme DERIVATIVES OF 7,8-DIHYDRO-1H-IMIDAZO[2,1-b]PURIN-4(5H)-ONE AND METHODS OF USE THEREOF
WO2011153136A1 (en) 2010-05-31 2011-12-08 Intra-Cellular Therapies, Inc. Organic compounds
US9371327B2 (en) 2010-05-31 2016-06-21 Intra-Cellular Therapies, Inc. PDE1 inhibitor compounds
TW201206937A (en) 2010-05-31 2012-02-16 Intra Cellular Therapies Inc Organic compounds
US9763948B2 (en) 2010-05-31 2017-09-19 Intra-Cellular Therapies, Inc. PDE1 inhibitory compounds and methods
WO2014127331A1 (en) 2013-02-17 2014-08-21 Intra-Cellular Therapies, Inc. Novel uses
RU2679142C2 (en) 2013-03-15 2019-02-06 Интра-Селлулар Терапиз, Инк. Organic compounds
JP2016518343A (en) 2013-03-15 2016-06-23 イントラ−セルラー・セラピーズ・インコーポレイテッドIntra−Cellular Therapies, Inc. A new use
EP3091983A4 (en) 2014-01-08 2017-07-05 Intra-Cellular Therapies, Inc. Products and pharmaceutical compositions
WO2015196186A1 (en) 2014-06-20 2015-12-23 Intra-Cellular Therapies, Inc. Organic compounds
US9546175B2 (en) 2014-08-07 2017-01-17 Intra-Cellular Therapies, Inc. Organic compounds
US10285992B2 (en) 2014-08-07 2019-05-14 Intra-Cellular Therapies, Inc. Combinations of PDE1 inhibitors and NEP inhibitors and associated methods
EP3177627A4 (en) 2014-08-07 2018-03-07 Intra-Cellular Therapies, Inc. Organic compounds
CA2961212A1 (en) 2014-09-17 2016-03-24 Intra-Cellular Therapies, Inc. Compounds and methods
BR112017012007A2 (en) 2014-12-06 2017-12-26 Intra Cellular Therapies Inc organic compounds
KR20170089001A (en) 2014-12-06 2017-08-02 인트라-셀룰라 써래피스, 인코퍼레이티드. Organic compounds

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1938016A1 (en) 1969-07-23 1971-01-28 Fischer Ohg Arzneimittelwerk Cold therapy with caffeine derivatives
FR2116302B1 (en) 1970-12-07 1974-06-21 Brun Lab Sa Le
EP0258191B1 (en) 1986-08-28 1992-05-27 Sandoz Ag Xanthine derivatives
US5321029A (en) * 1988-11-14 1994-06-14 Beecham-Wuelfing Gmbh & Co.K.G. Xanthines
GB8906792D0 (en) 1989-03-23 1989-05-10 Beecham Wuelfing Gmbh & Co Kg Treatment and compounds
FR2654935B1 (en) 1989-11-28 1994-07-01 Lvmh Rech Use of xanthines, optionally incorporated into liposomes, for promoting the pigmentation of the skin or hair.
GB9013750D0 (en) 1990-06-20 1990-08-08 Pfizer Ltd Therapeutic agents
IL98559D0 (en) * 1990-06-21 1992-07-15 Schering Corp Polycyclic guanine derivatives
GB9020959D0 (en) 1990-09-26 1990-11-07 Beecham Group Plc Novel compounds
GB9020921D0 (en) 1990-09-26 1990-11-07 Beecham Group Plc Novel compounds
AU649091B2 (en) * 1990-12-21 1994-05-12 Beecham Group Plc Xanthine derivatives
GB9210839D0 (en) 1992-05-21 1992-07-08 Smithkline Beecham Plc Novel compounds
GB9226532D0 (en) * 1992-12-21 1993-02-17 Smithkline Beecham Plc Compounds
IL108754D0 (en) 1993-02-26 1994-06-24 Schering Corp 2-benzyl-polycyclic guanine derivatives and process for preparing them
GB9301192D0 (en) 1993-06-09 1993-06-09 Trott Francis W Flower shaped mechanised table
GB9423911D0 (en) * 1994-11-26 1995-01-11 Pfizer Ltd Therapeutic agents
US5731339A (en) * 1995-04-28 1998-03-24 Zonagen, Inc. Methods and formulations for modulating the human sexual response
GB9514464D0 (en) * 1995-07-14 1995-09-13 Glaxo Lab Sa Medicaments
US5824683A (en) * 1995-11-28 1998-10-20 Schering Corporation 2'- 4'-halo- 1,1'-biphenyl!-4-yl!methyl!-5'-methyl-spiro cyclopentane-1,7' (8'H)- 3H! imidazo 2,1-b!purin!-4' (5'H)-ones
GB9612514D0 (en) * 1996-06-14 1996-08-14 Pfizer Ltd Novel process
US6403597B1 (en) * 1997-10-28 2002-06-11 Vivus, Inc. Administration of phosphodiesterase inhibitors for the treatment of premature ejaculation
US6037346A (en) * 1997-10-28 2000-03-14 Vivus, Inc. Local administration of phosphodiesterase inhibitors for the treatment of erectile dysfunction
CH693954A5 (en) 1997-11-12 2004-05-14 Bayer Ag 2-phenyl-substituted imidazotriazinones as phosphodiesterase inhibitors.
DE19816857A1 (en) 1998-04-16 1999-10-21 Boehringer Ingelheim Pharma Novel adenosine antagonists useful in treatment of e.g. neurodegenerative, pulmonary, renal and cardiovascular disorders
AU4501199A (en) 1998-06-03 1999-12-20 Almirall Prodesfarma S.A. 8-phenylxanthine derivatives and their use as phosphodiesterase inhibitors
US6087362A (en) * 1999-03-16 2000-07-11 Pentech Pharmaceuticals, Inc. Apomorphine and sildenafil composition
US6023640A (en) * 1999-03-29 2000-02-08 Ross; Jesse Method contributing to obviating male impotency
US20020091129A1 (en) * 2000-11-20 2002-07-11 Mitradev Boolell Treatment of premature ejaculation
AT395349T (en) * 2001-08-28 2008-05-15 Schering Corp Polycyclic guanine phosphodiesterase inhibitors

Also Published As

Publication number Publication date
EP1421084A1 (en) 2004-05-26
JP2005325138A (en) 2005-11-24
ES2302835T3 (en) 2008-08-01
AR036674A1 (en) 2004-09-29
CN1315835C (en) 2007-05-16
MXPA04001891A (en) 2004-06-15
US20030153587A1 (en) 2003-08-14
JP4450365B2 (en) 2010-04-14
US6969719B2 (en) 2005-11-29
CA2457944A1 (en) 2003-03-13
CN1781920A (en) 2006-06-07
CA2457944C (en) 2009-09-29
JP2005502684A (en) 2005-01-27
EP1421084B1 (en) 2008-05-14
CN1547583A (en) 2004-11-17
WO2003020724A1 (en) 2003-03-13
DE60226615D1 (en) 2008-06-26
PE04152003A1 (en) 2003-05-22
HK1064668A1 (en) 2008-12-24

Similar Documents

Publication Publication Date Title
DE60026297D1 (en) Pyrrolotriazine kinase inhibitor
DE60229891D1 (en) nebulizer
AT413654T (en) Diabetisbehandlungssystem
AT279154T (en) Ablationsatherektomiefräswerkzeug
AT464012T (en) Kryotemperaturüberwachung
AT462047T (en) Verschleissanordnung
AT369890T (en) Ballonfalttechnologie
AT312640T (en) Kompositführungsdraht
AT403872T (en) Massenspektormetrie-process
AT492210T (en) Mehrfunktionsluftwegadapter
AT464149T (en) Laserfräsverfahren and-system
AT303741T (en) Espressobrüheinrichtung
AT553775T (en) Impstoffzusammesetzung
AT322052T (en) Bildidentifierungssystem
AT392972T (en) Wendefrässchneidplatte
AT333236T (en) Intraokularlinsenbestimmungssystem
AT409966T (en) Vanadium - / - polyhalid-redoxflussbatterie
DE60232261D1 (en) s
AT383128T (en) Hüftimplantataufbau
AT305932T (en) Rapanycin29-enols
AT297845T (en) Krankenbett- Casters- device
AT480330T (en) Hand-pipetting
AT396243T (en) Verkokungskammerentleerungssystem
AT441451T (en) Lísungsauftragsvorrichtung
DE60319364D1 (en) Substituted -pyrrolines as kinase inhibitors

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties